Application of antibacterial peptide BP15 and derivative thereof in inhibiting plant anthracnose pathogenic bacteria

Antimicrobial peptide BP15 and its derivatives provide an effective and safe solution to control mango anthracnose by inhibiting Colletotrichum asiaticum, addressing the limitations of chemical fungicides and ensuring low toxicity and stability.

CN119054695APending Publication Date: 2024-12-03SICHUAN UNIVERSITY OF SCIENCE AND ENGINEERING
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411173373.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The long-term use of chemical fungicides for controlling postharvest anthracnose in mangoes induces drug resistance in pathogens and poses environmental and health risks, necessitating the development of efficient, low-toxic, and safe alternatives.

Method used

Application of antimicrobial peptide BP15 and its derivatives, such as Ac-BP15, HBP15, and LBP15, to inhibit plant anthracnose pathogens like Colletotrichum asiaticum, with minimum inhibitory concentrations ranging from 6.25 to 12.5 µmol/L and minimum bactericidal concentrations of 12.5 µmol/L.

Benefits of technology

The antimicrobial peptides effectively inhibit Asian spiny spore C. asiaticum, providing effective control of mango anthracnose and reducing the incidence and lesion diameter of anthracnose lesions in mango fruits, while maintaining low cytotoxicity and stability across various conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119054695A_ABST
    Figure CN119054695A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biological agents, and discloses application of antibacterial peptide BP15 and derivatives thereof in inhibiting plant anthracnose pathogenic bacteria. The antibacterial peptide BP15 and the derivative thereof are applied to inhibition of plant anthracnose for the first time, pathogenic bacteria of colletotrichum asiaticum can be effectively inhibited, effective control of mango anthracnose is realized, and a new thought is provided for prevention and treatment of anthracnose after mango harvesting.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biological preparations, and in particular to the application of antimicrobial peptide BP15 and its derivatives in inhibiting plant anthracnose pathogens. Background Art

[0002] After mangoes are harvested, the available nutrients increase and the resistance decreases. The pathogens that latently infect during the growth period gradually cause fruit diseases. Colletotrichum asianum Postharvest anthracnose of mango fruits caused by chlorpyrifos is one of the main pathogens of mangoes during storage. At present, chemical fungicides are the most common and effective means of controlling postharvest diseases of mangoes, such as carbendazim, prochloraz and chlorpyrifos. However, long-term use of chemical fungicides will induce drug resistance in pathogens, and their drug residues and various toxic effects also pose huge risks to the environment and human body. Therefore, finding efficient, low-toxic and safe alternatives has also become a key research direction for controlling postharvest anthracnose of mangoes.

[0003] In view of this, the present invention is proposed. Summary of the invention

[0004] The present invention aims to provide the use of antimicrobial peptide BP15 and its derivatives in inhibiting plant anthracnose pathogens.

[0005] The technical solution adopted by the present invention is: Application of antimicrobial peptide BP15 and its derivatives in inhibiting plant anthracnose pathogens.

[0006] Preferably, the derivative is selected from Ac-BP15, HBP15, and LBP15.

[0007] Preferably, the minimum inhibitory concentrations of the antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 against anthrax are 6.25, 12.5, 6.25 and 6.25 µmol / L.

[0008] Preferably, the minimum bactericidal concentrations of antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 against anthrax are all 12.5 µmol / L.

[0009] Compared with the prior art, the present invention has the following beneficial effects: The present invention is the first to apply the antimicrobial peptide BP15 and its derivatives to inhibit plant anthracnose pathogens, which can effectively inhibit the Asian spiny spore C. asianum , achieving effective control of mango anthracnose and providing new ideas for the prevention and control of post-harvest anthracnose in mangoes. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 BP15, Ac-BP15, HBP15 and LBP15 C. asianum Growth inhibition dose curves; Figure 2 A in the figure shows the number of surviving spores in the BP15 and Ac-BP15 treatment groups, and B shows the number of surviving spores in the HBP15 and LBP15 treatment groups; Figure 3 A and B are the spore growth pictures of four antimicrobial peptides: BP15, Ac-BP15, HBP15, and LBP15; Figure 4 For BP15, Ac-BP15, HBP15 and LBP15 C. asianum The effect of mycelial survival rate; Figure 5 A shows the effect of BP15, Ac-BP15, HBP15 and LBP15 on the incidence of anthracnose in mango fruit; B shows the effect of BP15, Ac-BP15, HBP15 and LBP15 on the diameter of anthracnose lesions in mango fruit; Figure 6 The symptoms of anthracnose in mango fruits in the control group and the antimicrobial peptide treatment group after 7 days of storage; Figure 7 For BP15, Ac-BP15, HBP15 and LBP15 C. asianum The influence of hyphae surface morphology; Figure 8 Fluorescence microscopy was used to observe the effects of BP15, Ac-BP15, HBP15 and LBP15 on C. asianum The influence of mycelial membrane integrity; Fig. 9 For BP15, Ac-BP15, HBP15 and LBP15 C. asianum Effects on spore membrane integrity; Fig.10 Fluorescence microscopy was used to observe the effects of BP15, Ac-BP15, HBP15 and LBP15 on C. asianum Effects on spore membrane integrity; Fig.11 The temperature stability of BP15, Ac-BP15, HBP15, and LBP15; Fig.12 The acid-base stability of BP15, Ac-BP15, HBP15, and LBP15; Fig.13 The AC in the middle are BP15, Ac-BP15, HBP15 and LBP15 for K + 、Na + and Ca 2+ stability; Fig.14The hemolytic activity of BP15, Ac-BP15, HBP15 and LBP15 on sheep erythrocytes. DETAILED DESCRIPTION

[0011] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with specific embodiments and accompanying drawings. It should be understood that these descriptions are exemplary only, and are not intended to limit the scope of the present invention. In addition, in the following description, the description of known structures and technologies is omitted to avoid unnecessary confusion of the concept of the present invention. In the embodiment, those who do not indicate specific conditions are carried out according to the conditions recommended by normal conditions or manufacturers. Those who do not indicate manufacturers for reagents or instruments used are conventional products that can be obtained by commercial purchase.

[0012] It should be noted that the sequence of the antimicrobial peptide BP15 is KKLFKKILKVL-NH2 (the peptide sequence is aminoacylated at the C-terminus), the sequence of the derivative Ac-BP15 is Ac-KKLFKKILKVL-NH2 (the peptide sequence is acetylated at the N-terminus and aminoacylated at the C-terminus), and the sequence of HBP15 is H 11 C6O-KKLFKKILKVL-NH2 (peptide sequence N-terminal link H 11 C6O-, C-terminal aminoacylation), the sequence of LBP15 is H 23 C 12 O-KKLFKKILKVL-NH2 (peptide sequence N-terminal link H 23 C 12 O-, C-terminal aminoacylation).

[0013] The antimicrobial peptide BP15 and its derivatives Ac-BP15, HBP15 and LBP15 used in the embodiments of the present invention are synthesized by chemical solid phase method at Nanjing GenScript Co., Ltd., with a purity of ≥95%, and stored in a -80°C refrigerator. Before use, they are diluted to 1 mmol / L or the maximum concentration of the mother solution with sterile deionized water or dimethyl sulfoxide (DMSO) reagent, and then diluted to the required concentration. In the following examples, the antimicrobial peptide BP15 and its derivatives are referred to as antimicrobial peptides.

[0014] Plant anthracnose pathogen Colletotrichum asiaticum used in the embodiments of the present invention Colletotrichum asianum It was isolated from mango fruit and identified by molecular biology and stored in the Agricultural Products Processing and Preservation Laboratory of Sichuan University of Science and Chemical Technology. C. asianum After culturing on potato dextrose agar (PDA) at 25 °C for 7 days, the conidia on the culture dish were rinsed with sterile deionized water, collected by filtration, counted with a hemocytometer, and further adjusted to the required concentration.

[0015] Example 1 Antimicrobial peptides against Colletotrichum asiatica C. asianumThe inhibitory effect 1.1 Effect of antimicrobial peptides on growth inhibition dose curve and minimum inhibitory concentration (MIC) determination 1×10 4 CFU / mL spore suspension, pipette 180µL C. asianum The spore suspension and 20 µL of 7.8, 15.6, 31.2, 62.5, 125, 250, 500 µmol / L and 1 mmol / L antimicrobial peptides and their derivatives were mixed in a 96-well microplate. The antimicrobial peptide solvent sterile water or DMSO was used as a control, and the 96-well microplate was placed in a 25 °C constant temperature incubator for 48 h and then its OD was measured using an ELISA reader. 600 The minimum inhibitory concentration (MIC) was the lowest concentration that could completely control the growth of pathogens after 48 h. Each treatment was repeated three times and the experiment was repeated three times. Figure 1 shown.

[0016] from Figure 1 It can be seen that the inhibitory effects of antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 were not obvious at low concentrations of 0.78 µmol / L and 1.56 µmol / L, but at a concentration of 3.12 µmol / L, the inhibitory effects of antimicrobial peptides on C. asianum When the concentrations of antimicrobial peptides BP15, HBP15 and LBP15 were 6.25 µmol / L and Ac-BP15 was 12.5 µmol / L, C. asianum Therefore, the MICs of antimicrobial peptides BP15, Ac-BP15, HBP15, and LBP15 were 6.25, 12.5, 6.25, and 6.25 µmol / L, respectively.

[0017] 1.2 Effect of antimicrobial peptides on the number of surviving spores and determination of the minimum bactericidal concentration (MFC) According to the four antimicrobial peptides in 1.1 C. asianum The experimental results of the growth inhibition dose curve were measured by an ELISA instrument. All the bacterial liquid in the 96-well plate was aspirated and spread on PDA plates respectively, and cultured at 25°C for 48 hours. The concentration at which almost no pathogens grew after 48 hours was the minimum bactericidal concentration (MFC). Each treatment was repeated three times, and the experiment was repeated three times. The experimental results are shown in Figure 2-3 shown.

[0018] Figure 2 A in the figure shows the number of surviving spores in the BP15 and Ac-BP15 treatment groups, and B shows the number of surviving spores in the HBP15 and LBP15 treatment groups; Figure 3The AD images are spore growth images of four antimicrobial peptides: BP15, Ac-BP15, HBP15, and LBP15. The concentrations of antimicrobial peptides in each treatment group were 0, 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50, and 100 µmol / L, respectively. Figure 2-3 It can be seen that when the concentrations of antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 were above 3.12 µmol / L, the greater the concentration of antimicrobial peptides, the greater the effect of C. asianum The more obvious the lethal effect of the spores, the more colonies were observed on the PDA plates when the concentrations of BP15, Ac-BP15, HBP15, and LBP15 were greater than 12.5 µmol / L.

[0019] 1.3 Effect of antimicrobial peptides on mycelial survival rate 1×10 was prepared with 5% PDB 4 CFU / mL C. asianum Spore suspension was cultured at 25 °C for 24 h. 90 µL of mycelial suspension and 10 µL of 7.8, 15.6, 31.2, 62.5, 125, 250, 500 µmol / L and 1 mmol / L antimicrobial peptides were added to a 96-well microplate and cultured for 2 h. 10 µL of 5 g / L MTT solution was added to the wells of the 96-well microplate using sterile water or DMSO as a control and cultured at 25 °C for 16 h. Finally, 100 µL of DMSO was added, and after the blue-purple precipitate in the well was completely dissolved, the absorbance at 570 nm was subtracted from the absorbance at 690 nm of the background material. Each treatment was repeated in three groups, and the experiment was repeated three times. The experimental results are shown in the following table. Figure 4 shown.

[0020] from Figure 4 It can be seen that when the concentration of antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 is 1.56 µmol / L, C. asianum The survival rate of mycelium gradually decreased. The mycelium was treated with antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 at MIC concentrations (6.25, 12.5, 6.25, 6.25 µmol / L). C. asianum After mycelia formation, the mycelial survival rate was less than 50%. At a concentration of 100 µmol / L, only 6.38%, 6.02%, 7.31%, and 4.8% of mycelia survived in the BP15, Ac-BP15, HBP15, and LBP15 treatment groups, respectively.

[0021] 1.4 Control effect of antimicrobial peptides on mango anthracnose After washing the mango with running water, place it in the room to dry naturally. Soak it in 75% alcohol for 30 seconds, 1% NaClO for 30 seconds, and sterile water for 2 times. Dry the surface moisture with sterile absorbent paper. Use an inoculation needle to pierce small holes near the equator on both sides of the mango fruit. Add 10 µL of the small holes on the front and back sides. C. asianum The spore suspension was used as the control group, and 10 μL of 1 mmol / L antimicrobial peptide and 90 μL of 1×10 6 CFU / mL spore suspension was used as the treatment group. After the liquid was completely absorbed, the mango fruits were placed in a storage box covered with moist sterile filter paper, sprayed evenly with a small amount of sterile water, and stored at room temperature. The incidence of mango fruits was counted and the diameter of fruit lesions was measured 4, 5, 6, and 7 days after inoculation. Each group of 10 mango fruits was repeated four times. The final concentrations of antimicrobial peptides BP15, Ac-BP15, HBP15, and LBP15 were all 100 µmol / L, compared with 1×10 5 CFU / mL C. asianum The spore suspension was mixed and inoculated immediately. Figure 5-6 shown.

[0022] Figure 5 A shows the effect of BP15, Ac-BP15, HBP15 and LBP15 on the incidence of anthracnose in mango fruit; B shows the effect of BP15, Ac-BP15, HBP15 and LBP15 on the diameter of anthracnose lesions in mango fruit. Figure 6 Symptoms of anthracnose in mango fruits in the control group and the antimicrobial peptide treatment group after 7 days of storage. Figure 5-6 It can be seen that the four antimicrobial peptides can control the occurrence of mango anthracnose to varying degrees. During the 4th to 7th day of storage, no fruit was diseased in the antimicrobial peptide BP15, Ac-BP15 and HBP15 treatment groups, while the incidence and lesion diameter of the LBP15 treatment group gradually increased during this period. On the 7th day, the incidence and lesion diameter of the LBP15 treatment group were 20% and 5.7 mm, respectively, but still significantly lower than the control group ( P<0.05 ).

[0023] 1.6 Antimicrobial peptides C. asianum Effect of mycelial surface morphology (1) Fixation: Add 18 ml of PDB medium and 2 ml of 1×10 6 CFU / mL C. asianumSpore suspension was cultured in a shaking incubator at 25 ℃ for 48 h, hyphae were collected, washed 3 times with sterile water and resuspended in the original volume of sterile water. 900 µL hyphae suspension and 100 µL 10×MIC or 1 mmol / L antimicrobial peptide were added to a 1.5 mL centrifuge tube and treated in a 25 ℃ incubator for 24 h. Sterile water was used as a control. After collecting hyphae by centrifugation at 4000 xg for 5 min, 1 ml 2.5% glutaraldehyde fixative (pH 7.2-7.4) was added respectively and fixed at 4 ℃ overnight. The fixed samples were washed 3 times with PBS solution, 5 min each time.

[0024] (2) Drying: Dehydrate the fixed mycelium samples by adding 1 mL of 30%, 50%, 70%, 80%, 90% and 95% ethanol solutions in sequence, each for 10 min, and then treat with 100% ethanol solution twice, each for 10 min. The treated samples were placed on a clean bench to air dry naturally. Finally, the samples were sprayed with gold, observed and photographed under a scanning electron microscope (SEM). The experimental results are shown in Figure 2. Figure 7 As shown, the scale bar is 5 μm. Figure 7 CK was the control group; A1, B1, C1, and D1 were MIC treatment groups; A2, B2, C2, and D2 were 100µmol / L treatment groups; the antimicrobial peptide in A1 and A2 treatment groups was BP15; the antimicrobial peptide in B1 and B2 treatment groups was Ac-BP15; the antimicrobial peptide in C1 and C2 treatment groups was HBP15; and the antimicrobial peptide in D1 and D2 treatment groups was LBP15.

[0025] from Figure 7 It can be seen that the unprocessed C. asianum The hyphae were normal in morphology and full, while the hyphae in the groups treated with different concentrations of antimicrobial peptides were damaged to some extent. BP15 showed local depression in the MIC treatment group, and the cell contents leaked a lot in the 100 μmol / L treatment group, and the mycelium was completely shrunken. However, the mycelium of Ac-BP15, HBP15 and LBP15 was severely twisted and deformed at low concentrations, and the hyphae were broken and shrunken.

[0026] 1.7 Antimicrobial peptides C. asianum Effect of mycelial membrane integrity Prepare 90 µL of 1×10 4 CFU / mL C. asianum The spore suspension was incubated at 25°C for 24 h. Then 10 μL of 10×MIC, 20×MIC, and 1 mmol / L antimicrobial peptide was added and incubated at 25°C for another 2 h. Sterile water was used as a control. The spores were centrifuged at 4°C, 6000 × g for 5 min, and the samples were collected. C. asianumMycelium was washed with sterile water for 3 times, and then resuspended in equal volume and added with 5.3 µL 4 µmol / L SYTOX Green (SG) solution. The samples were incubated in the dark at 25 °C for 5 min. The treated samples were washed with sterile water and resuspended in equal volume. They were observed and photographed using a fluorescence electron microscope. SG solution is a non-cell membrane permeable dye that can enter the cell after the cell membrane is damaged and bind to nucleic acid substances, emitting green fluorescence. It is often used in serious cell membrane integrity experiments. The experimental results are shown in Figure 2. Figure 8 As shown, the scale bar is 10 µm, CK is the control, A (B), C (D), E (F) and G (H) are the treatment groups of antimicrobial peptide BP15, Ac-BP15, HBP15 and LBP15 at concentrations of MIC, 2MIC and 100 µmol / L, respectively. CK1, A, C, E and G are under bright field conditions; CK2, B, D, F and H are under dark field conditions.

[0027] from Figure 8 It can be seen that the control group did not show green fluorescence, indicating C. asianum The mycelial membrane is intact. After treatment with antimicrobial peptides BP15, Ac-BP15 and HBP15 at MIC concentrations, Ac-BP15 mycelium showed spot-like fluorescence (Figure D1), and individual mycelium of BP15 and HBP15 showed weak continuous or fragmentary green fluorescence signals (Figures B1, F1). After treatment with LBP15 at MIC, small-area fluorescence appeared (Figure H1). In the groups treated with antimicrobial peptides BP15, Ac-BP15 and HBP15 at a concentration of 2MIC, the continuity and brightness of mycelial fluorescence were enhanced (Figures B2, D2, F2), and the area of ​​green fluorescence in the LBP15 treatment group was significantly increased (Figure H2). Under the action of high concentrations of antimicrobial peptides (100 μmol / L), the BP15 treatment group showed a large range of intermittent green fluorescence (Figure B3), and the Ac-BP15, HBP15 and LBP15 treatment groups showed a large range of continuous green fluorescence (Figures D3, F3, H3), and their fluorescence signals were bright, indicating that high concentrations of antimicrobial peptides severely destroyed C. asianum Integrity of hyphae. The four antimicrobial peptides in different concentrations all showed good cell membrane destruction, among which LBP15 showed a stronger effect than BP15, Ac-BP15 and HBP15. At low concentrations, continuous green fluorescence signals appeared in the hyphae, indicating that the diaphragm of the hyphae had been destroyed.

[0028] 1.8 Antimicrobial peptides C. asianum Effects on spore membrane integrity Then add 90 µL of 1×10 7 CFU / mL C. asianumThe spore suspension (containing 5% PDB) and 10 μL of 10×MIC, 20×MIC, and 1 mmol / L antimicrobial peptide were placed in a 1.5 mL centrifuge tube and cultured at 25°C for 6 h. Sterile water was used as a control. The spores were centrifuged at 4°C, 6000 × g for 5 min, and the samples were collected. C. asianum Spores were washed with PBS solution (pH 7.0), resuspended in 90 µL PBS solution, and then 10 µL 500 mg / L PI dye was added. The samples were incubated in the dark at 25 °C for 5 min. The treated samples were washed with PBS solution and resuspended in equal volumes. They were observed and photographed using a fluorescence electron microscope. Three fields of view were randomly observed on each slide, and the experiment was repeated twice. Among them, PI dye is a fluorescent dye that can pass through the damaged cell membrane and bind to the nucleic acid substances in the cell. Red fluorescence can be observed using a fluorescence microscope.

[0029] Calculate spore membrane integrity (MI) according to the following formula: , where N0 represents the total number of spores in the bright field, and N represents the number of stained spores.

[0030] The experimental results are as follows Figure 9-10 As shown, Fig. 9 For BP15, Ac-BP15, HBP15 and LBP15 C. asianum The effect of spore membrane integrity, Fig.10 Fluorescence microscopy was used to observe the effects of BP15, Ac-BP15, HBP15 and LBP15 on C. asianum Effects on spore membrane integrity, scale bar is 10 µm, CK is the control, A (B), C (D), E (F) and G (H) are the treatment groups of antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 at concentrations of MIC, 2MIC and 100 µmol / L, respectively. CK1, A, C, E and G are under bright field conditions; CK2, B, D, F and H are under dark field conditions.

[0031] Combination Figure 9-10 It can be seen that the control group had no fluorescent signal under the fluorescence microscope, proving that the spore membrane was intact, while the Ac-BP15, HBP15 and LBP15 treatment groups at the MIC concentration had stronger fluorescent signals ( Fig.10 D1, F1, H1), the membrane integrity was only 14.61%, 17.96% and 16.64%, and the BP15 treatment group had a weaker effect, with a membrane integrity of 39.02%, which was significantly lower than the control group ( P<0.05 ). With the increase of antimicrobial peptide concentration, the integrity of spore membrane gradually decreased. When the concentration was 100 μmol / L, the membrane integrity of the four antimicrobial peptides was no more than 6%, which could almost completely destroy the spore membrane.

[0032] Example 2 Determination of antibacterial stability and hemolytic activity of antimicrobial peptides and their derivatives 2.1 Thermal stability determination of antimicrobial peptides and their derivatives The 10×MIC antimicrobial peptide solution was heated in a water bath at 40°C, 50°C, 60°C, 70°C, and 80°C for 15 min. After cooling at room temperature for 30 min, 180 μL of 1×10 4 CFU / mL C. asianum Add the spore suspension (containing 5% PDB) and 20 µL of antimicrobial peptide to a 96-well plate and mix well. Place the 96-well plate in a 25 °C incubator for 48 h and measure the OD with a microplate reader. 600 The untreated antimicrobial peptide was used as the control. Each treatment group was repeated three times, and the experiment was repeated three times. Fig.11 shown.

[0033] from Figure 7 It can be seen that there is no significant difference between the four antimicrobial peptides treated groups at different temperatures and the corresponding control groups ( P> 0.05 The experimental results showed that the antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 were still active in the temperature range of 40-80 ℃. C. asianum It exhibits good antibacterial activity and has good thermal stability.

[0034] 2.2 Determination of acid-base stability of antimicrobial peptides and their derivatives The pH of the antimicrobial peptide solution (1 mmol / L) was adjusted to 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, and 10.0, respectively. After treatment at room temperature for 1 h, the pH was adjusted to 7.0, so that the final concentration of the antimicrobial peptide was 10×MIC. The antimicrobial peptide without pH adjustment was used as the control. The control was placed at room temperature for 1 h and then the pH was adjusted to 7.0. The spore suspension and the treated antimicrobial peptide were added as described in 3.2.3.1. After 48 h of incubation, the OD values ​​of the treated and control groups were measured. 600 The experimental results are as follows Fig.12 shown.

[0035] from Fig.12 It can be seen that at different pH values, the antimicrobial peptides Ac-BP15, HBP15, and LBP15 C. asianum The control effect of P>0.05 ). The antibacterial activity of antimicrobial peptide BP15 at pH 3 and 10 was significantly lower than that of the control group ( P<0.05). The results showed that the antimicrobial peptides BP15, HBP15 and LBP15 all had good acid-base stability and were not affected by pH; strong acid and strong base (pH 3.0 and pH 10.0) could significantly affect the antibacterial activity of the antimicrobial peptide BP15 ( P< 0.05 ).

[0036] 2.3 Determination of cationic stability of antimicrobial peptides and their derivatives 5, 20, 35, 50 mmol / L KCl solution, 50, 100, 150, 200 mmol / L NaCl solution and 1, 5, 25, 125 mmol / L CaCl2 solution sterilized at 121 ℃ were mixed with antimicrobial peptide solution (1 mmol / L) to make the final concentration of antimicrobial peptide 10×MIC. The antimicrobial peptide solution without cations (10×MIC) was used as the control. The spore suspension and the treated antimicrobial peptide were added as described in 3.2.3.1. After 48 h of incubation, the OD values ​​of the treated group and the control group were measured. 600 The experimental results are as follows Fig.13 As shown, Fig.13 The AC in the figure are BP15, Ac-BP15, HBP15 and LBP15 for the cation K + 、Na + and Ca 2+ stability.

[0037] from Fig.13 It can be seen that the antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 were + Processing is still C. asianum showed antibacterial activity, with no significant difference from the corresponding control group ( P>0.05 ).Depend on Figure 3-8 B shows that antimicrobial peptides BP15, Ac-BP15, and HBP15 only + (200 mmol / L), C. asianum The inhibitory activity of P<0.05 ). LBP15 in different Na + There was no significant difference between the concentration treatment and the control group ( P >0.05 ).Depend on Figure 3-8 C shows that BP15 is activated by Ca 2+ After treatment with concentrations of 50 and 100 mmol / L, the antibacterial activity of antimicrobial peptides was significantly reduced ( P<0.05 ), and as Ca 2+ The antibacterial effect of the antimicrobial peptide gradually weakened with the increase of concentration. 2+There was no significant difference between the control group and the control group (50mmol / L) P>0.05 ), and as Ca 2+ With the increase of concentration (100, 150, 200 mmol / L), the antibacterial activity of antimicrobial peptides was significantly lower than that of the corresponding control group ( P<0.05 ); HBP15 at low concentrations of Ca 2+ The antibacterial activity of the 50 and 100 mmol / L concentrations was reduced, but there was no significant difference compared with the control group ( P>0.05 ), while at higher Ca 2+ The antibacterial activity of antimicrobial peptides in the concentrations (150 and 200 mmol / L) was significantly lower than that in the control group ( P<0.05 ). LBP15 at different concentrations of Ca 2+ Under treatment C. asianum Maintained good antibacterial activity, with no significant difference compared with the control group ( P>0.05 ). The experimental results showed that the antimicrobial peptide LBP15 has good cationic stability, and different antimicrobial peptides have certain differences in sensitivity to different cation types and cation concentrations.

[0038] 2.4 Cytotoxicity assay of antimicrobial peptides and their derivatives Centrifuge 4% sheep red blood cells at 4 ℃, 1000xg, aspirate the lower red blood cells and resuspend them in 0.1 mol / L PBS buffer, wash 3 times, and resuspend them in the same volume of PBS. Pipette 180 µL of sheep red blood cell suspension and 20 µL of antimicrobial peptide or prochloraz solution (600 times dilution) into a 1.5 ml centrifuge tube, so that the final concentration of antimicrobial peptide is 3.12, 6.25, 12.5, 25, 50 and 100µmol / L, respectively, mix well, and incubate at 25 ℃ for 1 h. After centrifugation at 4 ℃, 1000 xg for 5 min, transfer the supernatant to a 96-well microplate and measure the OD with an enzyme-labeled instrument 580 The experiment used PBS as negative control and 0.1% Triton X-100 as positive control. Each treatment was repeated three times. The experimental results are shown in Fig.14 The hemolysis rate was calculated according to the following formula: ; Where: A represents the OD of the antimicrobial peptide treatment group 580 Value; A0 and A T Represents the OD of PBS-treated group and 0.1% Triton X-100-treated group, respectively. 580 value.

[0039] from Fig.14It can be seen that the antimicrobial peptides BP15 and Ac-BP15 have almost no hemolytic activity within the concentration range of 100 µmol / L. The hemolytic activity of the antimicrobial peptides HBP15 and LBP15 increases with the increase of their concentration, but the overall hemolytic activity is still low. When the concentration is 100 µmol / L, the hemolytic rates are 10.67% and 7.33%, respectively, which are significantly lower than the hemolytic rate of commercially available prochloraz (600 times solution) of 40% ( P<0.05 The results showed that BP15 and Ac-BP15 did not show hemolytic activity (<1%) even at a high concentration of 100 µmol / L, and the highest hemolytic rates of HBP15 and LBP15 did not exceed 15%. The four antimicrobial peptides all had low cytotoxicity, among which the antimicrobial peptides HBP15 and LBP15 had higher hemolytic rates. The reason may be that lipopeptides generally inhibit microorganisms non-selectively, and their hydrophobic structure increases their cytotoxicity to human cells to a certain extent.

[0040] Finally, it should be pointed out that the above embodiments are only representative examples of the present invention. Obviously, the technical solution of the present invention is not limited to the above embodiments, and there are many variations. All variations that can be directly derived or associated with the content of the present invention by a person skilled in the art should be considered as the protection scope of the claims of the present invention.

Claims

1. Application of antimicrobial peptide BP15 and its derivatives in inhibiting plant anthracnose pathogens.

2. The use according to claim 1, characterized in that The derivative is selected from Ac-BP15, HBP15, and LBP15.

3. The use according to claim 2, characterized in that The minimum inhibitory concentrations of antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 against anthrax were 6.25, 12.5, 6.25 and 6.25 µmol / L respectively.

4. The use according to claim 2, characterized in that The minimum bactericidal concentration of antimicrobial peptides BP15, Ac-BP15, HBP15 and LBP15 against anthrax was 12.5 µmol / L.